MOSCOW, March 10. /TASS/. Employees of the US pharmaceutical corporation Pfizer admit the fact of conducting directional evolution research for gaining competitive advantages and boosting profits, Chief of Russia’s Radiation, Chemical and Biological Protection Force Igor Kirillov told a briefing devoted to Washington’s military biological activities on Friday.
He noted the US Senate’s request to the Department of Health on ‘directional evolution’ research conducted by Pfizer. It attempted to estimate the credibility of information received by the American non profit organization Project Veritas from Pfizer Director of Research and Planning Jordan Walker. Among other things, he said that the company used the possibility of conducting ‘directional evolution’ research for improving the efficiency of its vaccines. Commenting on approaches to the creation of new vaccines, Walker said: why don’t we change the virus ourselves so that we could pre emptively develop new vaccines.
Consequently, Pfizer’s employee admits the fact of conducting ‘directional evolution’ research aimed at gaining competitive advantages and boosting profits, Kirillov concluded.
He also drew attention to the remarks by Pfizer’s former employee Karen Kingston, who said that the products of the US pharmaceutical company by definition, are biological weapons. Kingston cited US legislation that defines biological weapons as any biological agent, toxin or delivery vehicle, including vaccines with mRNA technology (messenger ribonucleic acid TASS).
Kirillov said that according to information at hand, the development of vaccines of this type had been bankrolled by the US budget since 2017 and by the time commercially available drugs appeared, it had been clear that they could cause the development of secondary diseases and serious complications such as meningitis, anaphylactic shock, acute myocardial infarction and stroke.
According to Kirillov, the side effects after the vaccination were supposed to be treated with medicines manufactured by Pfizer and Moderna, which have already received billions worth government contacts. Such an approach makes it possible for American pharmaceutical companies to fully use new pathogens in their interests and receive huge profits, he stressed.
MOSCOW, March 10. /TASS/. Employees of the US pharmaceutical corporation Pfizer admit the fact of conducting directional evolution research for gaining competitive advantages and boosting profits, Chief of Russia’s Radiation, Chemical and Biological Protection Force Igor Kirillov told a briefing devoted to Washington’s military biological activities on Friday.
He noted the US Senate’s request to the Department of Health on ‘directional evolution’ research conducted by Pfizer. It attempted to estimate the credibility of information received by the American non profit organization Project Veritas from Pfizer Director of Research and Planning Jordan Walker. Among other things, he said that the company used the possibility of conducting ‘directional evolution’ research for improving the efficiency of its vaccines. Commenting on approaches to the creation of new vaccines, Walker said: why don’t we change the virus ourselves so that we could pre emptively develop new vaccines.
Consequently, Pfizer’s employee admits the fact of conducting ‘directional evolution’ research aimed at gaining competitive advantages and boosting profits, Kirillov concluded.
He also drew attention to the remarks by Pfizer’s former employee Karen Kingston, who said that the products of the US pharmaceutical company by definition, are biological weapons. Kingston cited US legislation that defines biological weapons as any biological agent, toxin or delivery vehicle, including vaccines with mRNA technology (messenger ribonucleic acid TASS).
Kirillov said that according to information at hand, the development of vaccines of this type had been bankrolled by the US budget since 2017 and by the time commercially available drugs appeared, it had been clear that they could cause the development of secondary diseases and serious complications such as meningitis, anaphylactic shock, acute myocardial infarction and stroke.
According to Kirillov, the side effects after the vaccination were supposed to be treated with medicines manufactured by Pfizer and Moderna, which have already received billions worth government contacts. Such an approach makes it possible for American pharmaceutical companies to fully use new pathogens in their interests and receive huge profits, he stressed.
MOSCOW, March 10. /TASS/. Employees of the US pharmaceutical corporation Pfizer admit the fact of conducting directional evolution research for gaining competitive advantages and boosting profits, Chief of Russia’s Radiation, Chemical and Biological Protection Force Igor Kirillov told a briefing devoted to Washington’s military biological activities on Friday.
He noted the US Senate’s request to the Department of Health on ‘directional evolution’ research conducted by Pfizer. It attempted to estimate the credibility of information received by the American non profit organization Project Veritas from Pfizer Director of Research and Planning Jordan Walker. Among other things, he said that the company used the possibility of conducting ‘directional evolution’ research for improving the efficiency of its vaccines. Commenting on approaches to the creation of new vaccines, Walker said: why don’t we change the virus ourselves so that we could pre emptively develop new vaccines.
Consequently, Pfizer’s employee admits the fact of conducting ‘directional evolution’ research aimed at gaining competitive advantages and boosting profits, Kirillov concluded.
He also drew attention to the remarks by Pfizer’s former employee Karen Kingston, who said that the products of the US pharmaceutical company by definition, are biological weapons. Kingston cited US legislation that defines biological weapons as any biological agent, toxin or delivery vehicle, including vaccines with mRNA technology (messenger ribonucleic acid TASS).
Kirillov said that according to information at hand, the development of vaccines of this type had been bankrolled by the US budget since 2017 and by the time commercially available drugs appeared, it had been clear that they could cause the development of secondary diseases and serious complications such as meningitis, anaphylactic shock, acute myocardial infarction and stroke.
According to Kirillov, the side effects after the vaccination were supposed to be treated with medicines manufactured by Pfizer and Moderna, which have already received billions worth government contacts. Such an approach makes it possible for American pharmaceutical companies to fully use new pathogens in their interests and receive huge profits, he stressed.
MOSKAU, 10. März . TASS . Mitarbeiter des US-Pharmakonzerns Pfizer geben die Tatsache zu, dass Forschung zur gerichteten Evolution durchgeführt wird, um Wettbewerbsvorteile zu erzielen und Gewinne zu steigern, sagte der Chef der russischen Strahlen-, Chemikalien- und Bioschutztruppe, Igor Kirillov ein Briefing über Washingtons militärisch-biologische Aktivitäten am Freitag . Er nahm die Anfrage des US-Senats an das Gesundheitsministerium zur gerichteten Evolution zur Kenntnis Gewinnorganisation Project Veritas von Pfizer Direktor für Forschung und Planung Jordan Walker . Er sagte unter anderem, dass das Unternehmen die Möglichkeit der gerichteten Evolutionsforschung nutzte, um die Effizienz seiner Impfstoffe zu verbessern . Kommentierte Ansätze zur Entwicklung neuer Impfstoffe die Schaffung neuer Impfstoffe, sagte Walker: Warum verändern wir das Virus nicht selbst, damit wir präventiv neue Impfstoffe entwickeln können?
MOSCOU, 10 de março . TASS . Funcionários da empresa farmacêutica norte-americana Pfizer admitem o fato de conduzir pesquisas de evolução direcional para obter vantagens competitivas e aumentar os lucros, disse o chefe da Força de Proteção Química e Biológica da Rússia, Igor Kirillov. um briefing dedicado às atividades biológicas militares de Washington na sexta-feira . Ele observou o pedido do Senado dos EUA ao Departamento de Saúde sobre a pesquisa de evolução direcional conduzida pela Pfizer . Ele tentou estimar a credibilidade das informações recebidas pelo americano organização lucrativa Projeto Veritas da Pfizer Diretor de Pesquisa e Planejamento Jordan Walker . Entre outras coisas, ele disse que a empresa usou a possibilidade de conduzir pesquisas de evolução direcional para melhorar a eficiência de suas vacinas . Comentando sobre abordagens para a criação de novas vacinas a criação de novas vacinas, Walker disse: por que não mudamos nós mesmos o vírus para que possamos desenvolver preventivamente novas vacinas . Consequentemente, o funcionário da Pfizer admite o fato de conduzir pesquisas de evolução direcional com o objetivo de obter
